Odyssey Therapeutics, Inc. Common Stock (ODTX) — Financial Flexibility Index

Latest as of June 2026: -0.55x

Odyssey Therapeutics, Inc. Common Stock (ODTX) has a Financial Flexibility Index of -0.55x as of June 2026. Free cash flow of $-34.32 Million (operating CF $-34.51 Million minus capex $186.00K) represents -1% of total liabilities ($62.63 Million). Check asset resilience ratio of Odyssey Therapeutics, Inc. Common Stock to evaluate the company's liquid asset resilience ratio.

Financial Flexibility Index

-0.55x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-34.32 Million
Operating CF − Capex

Total Liabilities

$62.63 Million
USD

Capital Expenditures

$186.00K
USD

Odyssey Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2025)

Historical Financial Flexibility Index trend for Odyssey Therapeutics, Inc. Common Stock across 4 annual periods. Explore Odyssey Therapeutics, Inc. Common Stock debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Financial Flexibility Index for Odyssey Therapeutics, Inc. Common Stock (2022–2025)

Year-by-year free cash flow to debt coverage for Odyssey Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see Odyssey Therapeutics, Inc. Common Stock cash flow conversion.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.17x $-128.24 Million $-129.47 Million $758.07 Million ▲ +15.9%
2024 -0.20x $-116.71 Million $-117.47 Million $579.96 Million ▼ -2.6%
2023 -0.20x $-107.67 Million $-112.73 Million $549.23 Million ▼ -4.3%
2022 -0.19x $-86.81 Million $-99.84 Million $461.77 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities